oneplacenews
Source: Ars Technica
Summary
The FDA has approved a second species of carcass-eating flies for use in maggot therapy, which helps treat wounds by cleaning dead tissue. This development could improve healing processes and offer more options for patients with chronic wounds.
Why It Matters
The clearance of this new fly species for maggot therapy represents a significant advancement in wound care, particularly for patients with non-healing ulcers and other severe wounds. By providing a natural and efficient method for debridement, this treatment may reduce reliance on antibiotics and improve healing outcomes, showcasing the potential of innovative biotherapy in modern medicine.
